Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thyroid cancer
Debbie Chen, Brian Hung‐Hin Lang, Donald S.A. McLeod, et al.
The Lancet (2023) Vol. 401, Iss. 10387, pp. 1531-1544
Closed Access | Times Cited: 269

Showing 1-25 of 269 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 87
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Qingmiao Shi, Chen Xue, Yifan Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 84
Thyroid cancer trends in China and its comparative analysis with G20 countries: Projections for 2020–2040
Yi Gong, Qin Jiang, Mimi Zhai, et al.
Journal of Global Health (2024) Vol. 14
Open Access | Times Cited: 25
Fmoc-FF Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells
Enrico Gallo, Giovanni Smaldone, Luca Cimmino, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 263-263
Open Access | Times Cited: 2
A multicenter cohort study of thyroidectomy-related decision regret in patients with low-risk papillary thyroid microcarcinoma
Genpeng Li, Ruicen Li, Jinjing Zhong, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment
Suzette Delaloge, Seema A. Khan, Jelle Wesseling, et al.
The Lancet (2024) Vol. 403, Iss. 10445, pp. 2734-2746
Closed Access | Times Cited: 10
Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study
Debbie Chen, Grant Carr, Francis P. Worden, et al.
Thyroid (2024) Vol. 34, Iss. 7, pp. 837-845
Closed Access | Times Cited: 10
Bidirectional Association between Periodontitis and Thyroid Disease: A Scoping Review
Francesco Inchingolo, Angelo Michele Inchingolo, Alessio Danilo Inchingolo, et al.
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 7, pp. 860-860
Open Access | Times Cited: 10
AKR1C3 silencing inhibits autophagy‐dependent glycolysis in thyroid cancer cells by inactivating ERK signaling
Ying Gao, Weijie Tao, Shoujun Wang, et al.
Drug Development Research (2024) Vol. 85, Iss. 1
Closed Access | Times Cited: 9
Temporal trends of thyroid cancer in China and globally from 1990 to 2021: an analysis of the global burden of Disease Study 2021
Kaiyuan Huang, Xuanwei Huang, Shuoying Qian, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
DPP4, a potential tumor biomarker, and tumor therapeutic target: review
Lu Sun, Yuhui Ma, Chenchen Geng, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
Measurements of Iodination in Thyroglobulin: A Step Towards the Next Generation of Thyroid Cancer Monitoring
Anthony Maus, Chris Thompson, Stefan K. Grebe
Journal of the Endocrine Society (2025) Vol. 9, Iss. 3
Open Access | Times Cited: 1
Bisphenol A exposure enhances proliferation and tumorigenesis of papillary thyroid carcinoma through ROS generation and activation of NOX4 signaling pathways
Yi Wang, Xuling Su, Qianqian Wang, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 292, pp. 117946-117946
Closed Access | Times Cited: 1
Advances in targeted therapy and biomarker research in thyroid cancer
Mei Guo, Yuqi Sun, Yuyao Wei, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 8
Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasiexperimental Study of High- Versus Low-Adoption States
Yongmei Huang, Stephanie J. Chan, Jason D. Wright, et al.
Thyroid (2024) Vol. 34, Iss. 3, pp. 388-398
Closed Access | Times Cited: 7
Hypoxia expedites the progression of papillary thyroid carcinoma by promoting the CPT1A‐mediated fatty acid oxidative pathway
Liang Zhou, Hongsheng He, Bing Zhang, et al.
Drug Development Research (2024) Vol. 85, Iss. 2
Closed Access | Times Cited: 7
An enzyme-free sensing platform for miRNA detection and in situ imaging in clinical samples based on DNAzyme cleavage-triggered catalytic hairpin assembly
Hechen Wang, Minzhe Shen, Xudan Shen, et al.
Biosensors and Bioelectronics (2024) Vol. 256, pp. 116279-116279
Closed Access | Times Cited: 7
Thyroid Nodule Characterization: Overview and State of the Art of Diagnosis with Recent Developments, from Imaging to Molecular Diagnosis and Artificial Intelligence
Emanuele David, Hektor Grazhdani, Giuliana Tattaresu, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1676-1676
Open Access | Times Cited: 7
Global burden of thyroid cancer from 1990 to 2021: a systematic analysis from the Global Burden of Disease Study 2021
Tianjiao Zhou, Xiaoting Wang, Jingyu Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Methyltransferase-like 3 modifications of RNAs: Implications for the pathology in the endocrine system
Xiaojuan Su, Yi Qu, Dezhi Mu
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 3, pp. 167010-167010
Closed Access | Times Cited: 6
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Overview and Summary 2024
Young Joo Park, Eun Kyung Lee, Young Shin Song, et al.
International Journal of Thyroidology (2024) Vol. 17, Iss. 1, pp. 1-20
Open Access | Times Cited: 6
SETMAR Facilitates the Differentiation of Thyroid Cancer by Regulating SMARCA2‐Mediated Chromatin Remodeling
Wei Zhang, Xianhui Ruan, Yue Huang, et al.
Advanced Science (2024) Vol. 11, Iss. 32
Open Access | Times Cited: 6
Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells
Zhen Jin, Yadong Han, Jiaxin Zhang, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 5
Cancer-associated fibroblast-derived periostin promotes papillary thyroid tumor growth through integrin-FAK-STAT3 signaling
Xiaorui Jin, Qianmei Deng, Shuting Ye, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 3014-3028
Open Access | Times Cited: 5
Cytosolic Cadherin 4 promotes angiogenesis and metastasis in papillary thyroid cancer by suppressing the ubiquitination/degradation of β-catenin
Luyao Wu, Jian Xiao, Dandan Yi, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top